Safety of Oral Midazolam as a Perioperative Anxiolytic for Outpatient Dermatologic Procedures

CONCLUSION Oral midazolam administration was not associated with major adverse events including in the more intensively monitored group. This supports its use as an anxiolytic for outpatient dermatologic procedures.
Source: Dermatologic Surgery - Category: Dermatology Tags: Original Article Source Type: research